skip to content
Treatments for basal cell and squamous cell carcinoma of the skin Preview this item
ClosePreview this item
Checking...

Treatments for basal cell and squamous cell carcinoma of the skin

Author: Aaron Drucker; United States. Agency for Healthcare Research and Quality,; Brown University Center for Evidence-Based Medicine,
Publisher: Rockville (MD) : Agency for Healthcare Research and Quality (US), December 2017.
Series: Comparative effectiveness review, no. 199.; AHRQ publication, no. 17(18)-EHC033-EF.
Edition/Format:   eBook : Document : National government publication : EnglishView all editions and formats
Summary:
INTRODUCTION: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most common malignancies in the United States. There are many potential management strategies for BCCs and SCCs, and the choice of management strategy for an individual patient is not straightforward. We aimed to comprehensively collect information on the comparative effectiveness and safety of each currently used therapeutic  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Aaron Drucker; United States. Agency for Healthcare Research and Quality,; Brown University Center for Evidence-Based Medicine,
OCLC Number: 1042405221
Description: 1 online resource (1 PDF file (various pagings)) : illustrations.
Series Title: Comparative effectiveness review, no. 199.; AHRQ publication, no. 17(18)-EHC033-EF.
Responsibility: prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by: Brown Evidence-based Practice Center, Providence, RI ; investigators, Aaron Drucker [and seven others].

Abstract:

INTRODUCTION: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most common malignancies in the United States. There are many potential management strategies for BCCs and SCCs, and the choice of management strategy for an individual patient is not straightforward. We aimed to comprehensively collect information on the comparative effectiveness and safety of each currently used therapeutic strategy for both BCC and SCC. DATA SOURCES: We conducted literature searches in MEDLINE(r), the Cochrane Central Trials Registry and Cochrane Database of Systematic Reviews, and Embase(r) up to March 2017. We also perused the reference lists of published relevant clinical practice guidelines and systematic reviews. We recorded information on recurrence, histologic clearance, clinical clearance, patient- or observer-rated cosmetic outcomes, adverse effects, quality of life, costs and resources, mental health, patient satisfaction, and mortality. We estimated intervention effects (differences in outcomes between treatments) and the mean frequency of the outcome with each treatment using network meta-analyses. RESULTS: We identified 58 randomized controlled trials and 51 nonrandomized comparative studies comparing 21 interventions in 9 categories. Nearly all reported results for recurrence or cure rate outcomes and adverse events, and many reported results for cosmetic outcomes. Few studies reported results using validated instruments for quality of life, mental health, or patient satisfaction with treatment. Data were sparse, especially for analyses at the individual-intervention level. For BCCs, surgical interventions and radiation were associated with lower recurrence rates than interventions that destroy lesions with heat or cold and photodynamic therapy (PDT), and may have lower recurrence rates than curettage. Recurrence rates did not differ significantly between imiquimod and excision. The data were not sufficient to draw conclusions about the comparison of curettage with interventions that destroy lesions with heat or cold, or PDT versus other intervention categories. For SCC in situ, interventions that destroy the lesions with heat or cold and PDT were associated with lower recurrence rates than 5-fluorouracil. Data on the relative effect of thermal interventions versus PDT were not precise enough to draw conclusions. CONCLUSIONS: Based on sparse evidence, surgical and radiation treatments have lower recurrence rates than other modalities for the treatment of low-risk BCC, and PDT appears to have superior cosmetic outcomes. Large gaps remain in the literature regarding the comparison of individual interventions and SCC in situ, with very little or no information on immunocompromised patients, patients with limited life expectancy, and patients with specific lesion categories, including high-risk BCCs and invasive SCCs.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1042405221> # Treatments for basal cell and squamous cell carcinoma of the skin
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
    library:oclcnum "1042405221" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/mdu> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/5300064244#Topic/comparative_effectiveness_research> ; # Comparative Effectiveness Research
    schema:about <http://experiment.worldcat.org/entity/work/data/5300064244#Topic/skin_neoplasms_therapy> ; # Skin Neoplasms--therapy
    schema:about <http://experiment.worldcat.org/entity/work/data/5300064244#Topic/carcinoma_basal_cell_therapy> ; # Carcinoma, Basal Cell--therapy
    schema:about <http://experiment.worldcat.org/entity/work/data/5300064244#Topic/carcinoma_squamous_cell_therapy> ; # Carcinoma, Squamous Cell--therapy
    schema:author <http://experiment.worldcat.org/entity/work/data/5300064244#Person/drucker_aaron> ; # Aaron Drucker
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/5300064244#Organization/united_states_agency_for_healthcare_research_and_quality> ; # United States. Agency for Healthcare Research and Quality,
    schema:contributor <http://experiment.worldcat.org/entity/work/data/5300064244#Organization/brown_university_center_for_evidence_based_medicine> ; # Brown University Center for Evidence-Based Medicine,
    schema:datePublished "2017" ;
    schema:description "INTRODUCTION: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most common malignancies in the United States. There are many potential management strategies for BCCs and SCCs, and the choice of management strategy for an individual patient is not straightforward. We aimed to comprehensively collect information on the comparative effectiveness and safety of each currently used therapeutic strategy for both BCC and SCC. DATA SOURCES: We conducted literature searches in MEDLINE(r), the Cochrane Central Trials Registry and Cochrane Database of Systematic Reviews, and Embase(r) up to March 2017. We also perused the reference lists of published relevant clinical practice guidelines and systematic reviews. We recorded information on recurrence, histologic clearance, clinical clearance, patient- or observer-rated cosmetic outcomes, adverse effects, quality of life, costs and resources, mental health, patient satisfaction, and mortality. We estimated intervention effects (differences in outcomes between treatments) and the mean frequency of the outcome with each treatment using network meta-analyses. RESULTS: We identified 58 randomized controlled trials and 51 nonrandomized comparative studies comparing 21 interventions in 9 categories. Nearly all reported results for recurrence or cure rate outcomes and adverse events, and many reported results for cosmetic outcomes. Few studies reported results using validated instruments for quality of life, mental health, or patient satisfaction with treatment. Data were sparse, especially for analyses at the individual-intervention level. For BCCs, surgical interventions and radiation were associated with lower recurrence rates than interventions that destroy lesions with heat or cold and photodynamic therapy (PDT), and may have lower recurrence rates than curettage. Recurrence rates did not differ significantly between imiquimod and excision. The data were not sufficient to draw conclusions about the comparison of curettage with interventions that destroy lesions with heat or cold, or PDT versus other intervention categories. For SCC in situ, interventions that destroy the lesions with heat or cold and PDT were associated with lower recurrence rates than 5-fluorouracil. Data on the relative effect of thermal interventions versus PDT were not precise enough to draw conclusions. CONCLUSIONS: Based on sparse evidence, surgical and radiation treatments have lower recurrence rates than other modalities for the treatment of low-risk BCC, and PDT appears to have superior cosmetic outcomes. Large gaps remain in the literature regarding the comparison of individual interventions and SCC in situ, with very little or no information on immunocompromised patients, patients with limited life expectancy, and patients with specific lesion categories, including high-risk BCCs and invasive SCCs."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/5300064244> ;
    schema:genre "Government publication"@en ;
    schema:genre "Review"@en ;
    schema:genre "National government publication"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/5300064244#Series/ahrq_publication> ; # AHRQ publication ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/5300064244#Series/comparative_effectiveness_review> ; # Comparative effectiveness review ;
    schema:name "Treatments for basal cell and squamous cell carcinoma of the skin"@en ;
    schema:productID "1042405221" ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK487552> ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK487552/> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1042405221> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/5300064244#Organization/brown_university_center_for_evidence_based_medicine> # Brown University Center for Evidence-Based Medicine,
    a schema:Organization ;
    schema:name "Brown University Center for Evidence-Based Medicine," ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Organization/united_states_agency_for_healthcare_research_and_quality> # United States. Agency for Healthcare Research and Quality,
    a schema:Organization ;
    schema:name "United States. Agency for Healthcare Research and Quality," ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Person/drucker_aaron> # Aaron Drucker
    a schema:Person ;
    schema:familyName "Drucker" ;
    schema:givenName "Aaron" ;
    schema:name "Aaron Drucker" ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Series/ahrq_publication> # AHRQ publication ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1042405221> ; # Treatments for basal cell and squamous cell carcinoma of the skin
    schema:name "AHRQ publication ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Series/comparative_effectiveness_review> # Comparative effectiveness review ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1042405221> ; # Treatments for basal cell and squamous cell carcinoma of the skin
    schema:name "Comparative effectiveness review ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Topic/carcinoma_basal_cell_therapy> # Carcinoma, Basal Cell--therapy
    a schema:Intangible ;
    schema:name "Carcinoma, Basal Cell--therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Topic/carcinoma_squamous_cell_therapy> # Carcinoma, Squamous Cell--therapy
    a schema:Intangible ;
    schema:name "Carcinoma, Squamous Cell--therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Topic/comparative_effectiveness_research> # Comparative Effectiveness Research
    a schema:Intangible ;
    schema:name "Comparative Effectiveness Research"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5300064244#Topic/skin_neoplasms_therapy> # Skin Neoplasms--therapy
    a schema:Intangible ;
    schema:name "Skin Neoplasms--therapy"@en ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.